04:17 PM EDT, 10/10/2025 (MT Newswires) -- Edward M. Kaye, Director, on October 08, 2025, sold 25,000 shares in Stoke Therapeutics ( STOK ) for $750,000. Following the Form 4 filing with the SEC, Kaye has control over a total of 49,124 common shares of the company, with 49,124 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1623526/000152278025000007/xslF345X05/form4-10102025_081021.xml